Abstract
In 2004, the Scottish Government recognised that “Hepatitis C is one of the most serious and significant public health risks of our generation” [1] . By December 2006, Health Protection Scotland (HPS) estimated that 50,000 people in Scotland had been infected with the hepatitis C virus (HCV) and that 38,000 were chronic carriers (Figure 1) [2]. Following an extensive consultation in 2005, the Health Minister and Chief Medical Officer launched Scotland’s ‘Action Plan for Hepatitis C’ in September 2006 [3].
Its aims are:
•To prevent the spread of hepatitis C, particularly among intravenous drug users (IDUs);
•To diagnose hepatitis C-infected people, particularly those who would most benefit from treatment; and
•To ensure that those infected receive optimal treatment, care and support.
Its aims are:
•To prevent the spread of hepatitis C, particularly among intravenous drug users (IDUs);
•To diagnose hepatitis C-infected people, particularly those who would most benefit from treatment; and
•To ensure that those infected receive optimal treatment, care and support.
| Original language | English |
|---|---|
| Pages (from-to) | 1-2 |
| Number of pages | 2 |
| Journal | Eurosurveillance |
| Volume | 13 |
| Issue number | 4-6 |
| Publication status | Published - 2008 |
Keywords
- hepatitis C
- Scotland
- intravenous drug users
